Brava COVID-19 Antibody Panel

Brava Diagnostics has developed the Brava COVID-19 Antibody Panel of to assess exposure and possible immunity against the SAR-CoV-2 virus. Results for IgM and IgG are reported.


The critical role of serology testing in fighting COVID-19

  • Identifying whether people have been exposed to SARS-CoV-2 and have mounted an immune response.
  • Assessing seroprevalence, i.e., counting how many people in a community have been exposed to SARS-CoV-2, by identifying individuals who have developed antibodies to the virus.
  • Identifying individuals who may be able to donate convalescent plasma as a possible treatment to patients who are seriously ill with COVID-19.
  • In the future, this test, along with other clinical data, may help identify individuals who may be less susceptible to infection and can return to work.

Serology testing in hot spots

  • Hospital workers
  • Residents and employees of nursing homes and assisted living facilities
  • Staff and inmates in prisons and jails
  • Essential workplaces, such as food processing plants and grocery stores
  • Community testing, particularly in areas with widespread outbreaks